Application of nano-drug delivery for treatment of myocardial infarction and its complications
DOI:
Author:
Affiliation:

1.Deparment of Cardiovascular Medicine, the 2nd Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China;2.College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang 150081, China;3.The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, Heilongjiang 150001, China;4.Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin, Heilongjiang 150081, China)

Clc Number:

R542.2

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Myocardial infarction (MI) and its concomitant malignant arrhythmia, pathological ventricular remodeling and other complications are seriously harmful to human health. At present, drug therapy is the main strategy to stabilize plaque and reduce myocardial ischemia-reperfusion injury. Recent studies have shown that nano-drug delivery has great potential to benefit targeted therapy and enhance the safety and efficacy of drug treatment. This paper summarizes the present development of nano-drug delivery, and reviews the prospects of the treatment of myocardial infarction and its complications.

    Reference
    Related
    Cited by
Get Citation

PIAO Minghui, QU Wenbo, LIU Bing, TIAN Jinwei. Application of nano-drug delivery for treatment of myocardial infarction and its complications[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2021,29(11):989-994.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:May 19,2020
  • Revised:June 20,2020
  • Adopted:
  • Online: November 18,2021
  • Published:
Article QR Code